SwedenResearch and clinical trials
40 years of laboratory data in Sweden: Zellweger spectrum occurs in about one in 74 thousand births
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
All patients diagnosed with a peroxisomal disorder in Sweden were studied. The data came from the records of the country's two laboratories for 1985–2024. In the 2005–2024 period, the frequency of Zellweger spectrum was about one in 73,800 births. Over the years, age at diagnosis and survival increased. The authors attribute this to better recognition of mild forms and improvements in supportive care.
What does it mean for patients and families?
This study is based on real patient records. It shows that mild forms are now being recognized more often. There is no similar count for Türkiye yet.
Source
PubMed (European Journal of Paediatric Neurology): Peroxisomal disorders - incidences in Sweden.
Scientific paper: Peroxisomal disorders - incidences in Sweden. European Journal of Paediatric Neurology, 2026. DOI: 10.1016/j.ejpn.2026.06.006 · PubMed 42341515
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Zellweger spectrum disorder (ZSD)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.